contact@streetstat.com

We ask the right questions
X

Martin N. Streeter brings over 30 years of international executive deployment of mission-critical software systems in compliance with FDA/EMA regulatory guidelines. He started his career as a biostatistics/database expert on the original Bolt Beranek and Newman (BBN) Clintrial software team (back in the early '80s). He got lucky and participated in an early angel investment round funding PAREXEL International (now a multi-billion $ CRO). Along the way, he raised >$1M in venture capital funding to launch and run his own company Invantage, Inc. - an entity focused on creating trusted alliances between physicians and industry, thereby accelerating and reducing pivotal Phase III trial startup costs. Invantage was acquired by Perceptive Informatics (a wholly-owned subsidiary of PAREXEL International) in September 2002. Working over 10K hours, he gained a deep intuitive understanding of pre-clinical and drug development processes capped via authorship of corporate-wide quality control guidelines and standard operating procedures (SOPs). More recently, at Massachusetts Medical Angels (MA2), he has played a vital role in the screening and deep-dive due diligence reviews of early-stage Life Science, Healthcare IT, and Medical Device investment opportunities. Martin holds a BA in Molecular, Cellular, and Developmental Biology from the University of Colorado and an MS in Biometry/Biostatistics from Case Western Reserve University.

MNS

 

 

 

 

Current interest in understanding pivots in building teams to implement strategies to change how healthcare data is generated and accessed.

  • Technical expertise: we realize that the best data scientists typically have deep knowledge of the science and how to describe it in software.
  • Curiosity: we are open to listening to suggestions and seek a sense of curiosity toward the entire team’s thinking and viewpoints.
  • Storytelling: an ability to connect and build partnership concepts to accelerate digital health advancements.
  • Cleverness: looking at a problem from a non-traditional, creative angle.

 With the state of the economy, people are afraid of not being able to get ahead. This leads to retrenchment and reduced risk appetite. Unfortunately, jobs are created by individuals taking risks in starting up new businesses. With no new companies, employment growth begins to slow. That is why we find ourselves – sadly for many – in an economic cycle with uncertainty in the future. What we need are entrepreneurs who enjoy going off the beaten path, who also believe in themselves and might just want to expand upon their ideas by hiring skilled workers. So we must ask, - Are you willing to take on some risk?

Old Style Network